数据链接：
官方服务：
资源简介：
Pre- and post-EndoPredict chemotherapy consensus.
应用场景：
创建时间：
2020-03-11
相关数据集
Table_5_Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy.xlsx
BackgroundMetabolic reprogramming is a well-known hallmark of cancer. Systematical identification of clinically relevant metabolic subtypes of Hepatocellular carcinoma (HCC) is critical to understand
NIAID Data Ecosystem40
Association of tumor immune microenvironment-related markers with efficacy of everolimus in premenopausal women with hormone receptor - positive / human epidermal growth factor receptor 2 - negative advanced breast cancer : preliminary results from MIRACLE trial
Association of tumor immune microenvironment-related markers with efficacy of everolimus in premenopausal women with hormone receptor - positive / human epidermal gro
Figshare2025-02-25 更新30
WP229 - Irinotecan pathway - Homo sapiens
This pathway shows the biotransformation of the chemotherapy prodrug irinotecan to form the active metabolite SN-38, an inhibitor of DNA topoisomerase I. SN-38 is primarily metabolized to the inactive
NIAID Data Ecosystem10
Circulant VEGF-A as a predictor of benefit for bevacizumab therapy for breast cancer patients: systematic review and meta-analysis
Systematic review protocol registration
DataCite Commons2020-08-03 更新30
Table1_Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types.XLSX
Cervical cancer is the fourth most commonly diagnosed cancer worldwide and, in almost all cases is caused by infection with highly oncogenic Human Papillomaviruses (HPVs). On the other hand, inflammat
NIAID Data Ecosystem20
